4.8 Editorial Material

Patient reported outcome assessment must be inclusive and equitable

期刊

NATURE MEDICINE
卷 28, 期 6, 页码 1120-1124

出版社

NATURE PORTFOLIO
DOI: 10.1038/s41591-022-01781-8

关键词

-

资金

  1. Health Research (NIHR), UK Research and Innovation (UKRI)
  2. NIHR Birmingham Biomedical Research Centre
  3. NIHR Surgical Reconstruction and Microbiology Research Centre
  4. NIHR ARC West Midlands, UK SPINE
  5. University Hospitals Birmingham NHS Foundation Trust
  6. Innovate UK
  7. UCB Pharma
  8. Gilead
  9. Takeda
  10. Merck
  11. Glaukos
  12. Patient-Centered Outcomes Research Institute
  13. NIHR Birmingham BRC
  14. NIHR ARC West Midlands
  15. Gilead Sciences Ltd
  16. NIHR Applied Research Collaboration (ARC) West Midlands
  17. Cochlear Ltd
  18. Association of Community Cancer Centers
  19. Pfizer
  20. PCORI, NIH
  21. AHRQ
  22. Hematology/Oncology Pharmacy Association
  23. Cancer and Aging Research Group (CARG)
  24. UroGen Pharma Ltd.
  25. NIHR Surgical Reconstruction and Microbiology Research Centre (SRMRC)
  26. NIHR Postdoctoral Fellowship Award
  27. NIHR Clinical Doctoral Research Fellowship Award
  28. European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group
  29. Roche
  30. Eisai
  31. Yorkshire Cancer Research
  32. Merck Healthcare KGaA, Darmstadt, Germany
  33. Medicines and Healthcare products Regulatory Agency

向作者/读者索取更多资源

\

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据